We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Epocrates and M3 Create Global Physician Research Panel

By HospiMedica International staff writers
Posted on 17 Jan 2012
Epocrates (San Mateo, CA, USA) and M3 (Tokyo; Japan) have announced a partnership to create the world's largest verified physician and healthcare provider panel, offering a global market research sampling solution.

The Epocrates market research panel is comprised of verified US physicians and other healthcare professionals who use the company's mobile clinical reference application, creating stronger engagement and higher responsiveness. More...
It is recognized industry-wide for its honesty and sample representation, providing clients the ability to recruit respondents based on specialty, years in practice, geography, and other demographic variables.

M3 operates globally with physician communities across the world via various professional web portals, including m3 dot com, MDLinx dot com, Doctors dot net dot uk, Medquarter dot de, and Medigate dot net, which has enabled the development of a proprietary healthcare professional panel with international diversity and extensive reach. The new unified panel covers more than 70 countries with more than 1.7 million physicians globally, providing more accurate targeting and sample specificity, and will offer investors, research firms, and pharmaceutical marketers greater access to qualified physicians and other healthcare professionals in the top medical specialties, including oncology, cardiology, and family practice.

“An audit within the industry revealed that M3 has the same quality assurance and values that we uphold for our research business,” said Peter Brandt, interim president and CEO of Epocrates. “Together, we are elevating the integrity and delivery standards across the research industry.”

“Both companies have established deep relationships with panel members, providing faster turnaround and more quality responders all over the world,” said Aki Tomaru, CEO of M3. “The goal of this partnership is to create some of the best healthcare market research coverage globally, featuring more consistent and comprehensive solutions for the industry.”

Epocrates offers various mobile health software applications, mostly for health care providers, providing them reference information about drugs, diseases, and diagnostic tools. Among the software functions is checking for drug interactions, news feeds for product announcements and medical news, journal article lookup, and a mobile guide to ICD-9 and Current Procedural Terminology ("CPT") diagnosis codes. The company markets both free and multiple paid versions, and receives additional revenue from pharmaceutical companies.

Related Links:

Epocrates
M3



Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Cervical Seal
Omni Lok
New
Leg Wraps
Leg Wraps
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The Minder Implant can record brain activity continuously for very long periods (Photo courtesy of Epiminder)

Implantable Device Continuously Monitors Brain Activity in Epileptic Patients

Epilepsy is one of the most prevalent and serious chronic neurological disorders, impacting around 52 million people globally. It is characterized by recurrent seizures, which are caused by abnormal electrical... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.